Neuronal characteristics of small-cell lung cancer

por Onganer, P U, Seckl, M J, Djamgoz, M B A
Publicado 2005

Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992–98

por Ronco, G, Pilutti, S, Patriarca, S, Montanari, G, Ghiringhello, B, Volante, R, Giordano, L, Zanetti, R, Mancini, E, Segnan, N
Publicado 2005

Proton beam therapy

por Levin, W P, Kooy, H, Loeffler, J S, DeLaney, T F
Publicado 2005

Sex hormones and oesophageal adenocarcinoma: influence of childbearing?

por Lagergren, J, Jansson, C
Publicado 2005

An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer

por Forrest, L M, McMillan, D C, McArdle, C S, Dunlop, D J
Publicado 2005

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53

por Szybka, M, Zawlik, I, Kulczycka, D, Golanska, E, Jesien, E, Kupnicka, D, Stawski, R, Piaskowski, S, Bieniek, E, Zakrzewska, M, Kordek, R, Liberski, P P, Rieske, P
Publicado 2008

Clinical anticancer drug development: targeting the cyclin-dependent kinases

por Benson, C, Kaye, S, Workman, P, Garrett, M, Walton, M, de Bono, J
Publicado 2005

Intensity-modulated radiation therapy: emerging cancer treatment technology

por Hong, T S, Ritter, M A, Tomé, W A, Harari, P M
Publicado 2005

Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors

por Weber, F, Fukino, K, Sawada, T, Williams, N, Sweet, K, Brena, R M, Plass, C, Caldes, T, Mutter, G L, Villalona-Calero, M A, Eng, C
Publicado 2005

Alcohol dehydrogenase 1B (ADH1B) genotype, alcohol consumption and breast cancer risk by age 50 years in a German case–control study

por Lilla, C, Koehler, T, Kropp, S, Wang-Gohrke, S, Chang-Claude, J
Publicado 2005

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

por Valle, J W, Dangoor, A, Beech, J, Sherlock, D J, Lee, S M, Scarffe, J H, Swindell, R, Ranson, M
Publicado 2005

Galectin-1 as a potential cancer target

por Rabinovich, G A
Publicado 2005

The role of dendritic cell precursors in tumour vasculogenesis

por Coukos, G, Benencia, F, Buckanovich, R J, Conejo-Garcia, J R
Publicado 2005

HMG CoA reductase inhibitors (statins) to treat Epstein–Barr virus-driven lymphoma

por Cohen, J I
Publicado 2005

Role of novel targeted therapies in the clinic

por Herbst, R S
Publicado 2005

Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis

por Renehan, A G, Egger, M, Saunders, M P, O'Dwyer, S T
Publicado 2005

Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation

por Milano, G, Ferrero, J-M, François, E
Publicado 2004

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study

por Ficorella, C, Morelli, M F, Ricevuto, E, Cannita, K, Porzio, G, Baldi, P Lanfiuti, Cianci, G, Rocco, ZC Di, Natoli, C, Tinari, N, Galitiis, F De, Calista, F, Marchetti, P
Publicado 2004

The relationship between aberrant methylation and survival in non-small-cell lung cancers

por Toyooka, S, Suzuki, M, Maruyama, R, Toyooka, K O, Tsukuda, K, Fukuyama, Y, Iizasa, T, Aoe, M, Date, H, Fujisawa, T, Shimizu, N, Gazdar, A F
Publicado 2004

Physical activity, body weight, and pancreatic cancer mortality

por Lee, I-M, Sesso, H D, Oguma, Y, Paffenbarger, R S
Publicado 2003